Medtronic’s Hugo Surgery Robot Enters European Market
Medtronic’s robotic-assisted surgery system earned a CE mark approval for urologic and gynecologic procedures, which make up about half of all robotic procedures.
You may also be interested in...
Medtronic announced on 19 October its robotic-assisted system Hugo has gained regulatory approvals in Japan, the third largest robotics market worldwide, and general surgery approval in the EU and Canada. A surgeon offered perspectives on Hugo versus Intuitive Surgical’s da Vinci surgical robot.
Health Canada has licensed Hugo for urologic and gynecologic laparoscopic surgical procedures.
The company originally expected the first-in-human trial of the soft-tissue robotic surgery system to begin in late 2022 and reach the market by 2023, but the company now expects those trials to begin in 2024.